DOCSLIB.ORG

Crosswalk Dsm-Iv – Dsm V – Icd-10 6.29.1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

CROSSWALK DSM-IV – DSM V – ICD-10 6.29.1 DSM IV DSM IV DSM-IV Description DSM 5 Classification DSM- 5 CODE/ DSM-5 Description Classification CODE ICD 10 CODE Schizophrenia 297.1 Delusional Disorder Schizophrenia F22 Delusional Disorder 298.8 Brief Psychotic Disorder Spectrum and Other F23 Brief Psychotic Disorder 295.4 Schizophreniform Disorder Psychotic Disorders F20.81 Schizophreniform Disorder 295.xx Schizophrenia F20.9 Schizophrenia (DSM IV had different subtypes) 295.7 Schizoaffective Disorder F25.x Schizoaffective Disorder F25.0 Bipolar type F25.1 Depressive type 293.xx Psychotic Disorder Due To F06.X Psychotic Disorder Due to Another Medical Condition .81 With delusions F06.2 With delusions .82 With hallucinations F06.0 With hallucinations 293.89 Catatonic Disorder Due to . F06.1 Catatonia Associated with Another Mental . (was classified as Mental Disorder Disorders Due to a General F06.1 Catatonic Disorder Due to Another Medical Medical Condition No Condition Elsewhere Classified) F06.1 Unspecified Catatonia ___.___ Substance-Induced ___.___ Substance/Medications-Induced Psychotic _ Psychotic Disorder Disorder 29809 Psychotic Disorder NOS F28 Other Specified Schizophrenia Spectrum and Other Psychotic Disorder F29 Unspecified Schizophrenia Spectrum and Other Psychotic Disorder 297.3 Shared Psychotic Disorder Removed in DSM5 1 CROSSWALK DSM-IV – DSM V – ICD-10 6.29.1 DSM IV DSM IV DSM-IV Description DSM 5 Classification DSM- 5 CODE/ DSM-5 Description Classification CODE ICD 10 CODE Bipolar and 296.xx Bipolar I Disorder Bipolar and Related __.__ Bipolar I Disorder Related .0x Single Manic Episode Disorders __.__ Current or most recent episode manic Disorders F31.11 Mild .4x Most Recent Episode Manic F31.12 Moderate F31.13 Severe F31.2 With psychotic features F31.73 In partial remission F31.74 In full remission F31.9 Unspecified .40 Most Recent episode F31.0 Current or most recent episode hypomanic Current or .6x Most Recent Episode Mixed most recent episode F31.73 In partial remission F31.74 In full remission F31.9 Unspecified .5x Most Recent Episode Current or most recent episode depressed Depressed F31.31 Mild F31.32 Moderate F31.4 Severe F31.5 With psychotic features F31.73 In partial remission F31.74 In full remission .7 F31.9 Unspecified 296.89 Bipolar II Disorder F31.81 Bipolar II Disorder F34.0 Cyclothymic Disorder __.__ Substance Induced Mood __.__ Substance/Medication-Induced Bipolar and Disorder Related Disorder 293.83 Mood Disorder Due To . F06.33 Bipolar and related Disorder Due to Another F06.33 W/manic features W/manic or hypomanic-like episode F06.34 Medical Condition (manic or mixed) 296.8 Bipolar Disorder NOS F31.89 Other Specified Bipolar & Related Disorder F31.9 Unspecified Bipolar and Related Disorder 2 CROSSWALK DSM-IV – DSM V – ICD-10 6.29.1 DSM IV DSM IV DSM-IV Description DSM 5 Classification DSM- 5 CODE/ ICD 10 DSM-5 Description Classification CODE CODE Mood Depressive F34.8 Disruptive Mood Dysregulation Disorder Depressive 296.xx Major Depressive Disorders __.__ Major Depressive Disorder Disorders Disorder .2X Single Episode __.__ Single episode F32.0 Mild F32.1 Moderate F32.2 Severe F32.3 With psychotic features F32.4 In partial remission F32.5 In full remission F32.9 Unspecified .3x Recurrent __.__ Recurrent Episode F33.0 Mild F33.1 Moderate F33.2 Severe F33.3 With psychotic features F33.41 In partial remission F33.42 In full remission F33.0 Unspecified 300.4 Dysthymic Disorder F34.1 Persistent Depressive Disorder (Dysthymia) N94.3 Premenstrual Dysphoric Disorder __.__ Substance/Medication-Induced Depressive Disorder __.__ Depressive Disorder Due to Another Medical Condition F06.31 With depressive features F06.32 With major depressive-like episode F06.34 With mixed features 296.90 Mood Disorder NOS F32.8 Other Specified Depressive Disorder F32.9 Unspecified Depressive Disorder 3 CROSSWALK DSM-IV – DSM V – ICD-10 6.29.1 DSM IV DSM IV DSM-IV Description DSM 5 Classification DSM- 5 CODE/ ICD 10 DSM-5 Description Classification CODE CODE Anxiety Disorders 309.1 Separation Anxiety Anxiety Disorders F93.0 Separation Anxiety Disorder Disorder 313.23 Selective Mutism F94.0 Selective Mutism 300.29 Specific Phobia __.__ Specific Phobia F40.218 Animal F40.228 Natural environment __.__ Blood-injection-injury F40.230 Fear of blood F40.231 Fear of injections and transfusions F40.232 Fear of other medical care F40.233 Fear of injury F40.248 Situational F40.298 Other 300.23 Social Phobia F40.10 Social Anxiety Disorder (Social Phobia) 300.01 Panic Disorder Without F41.0 Panic Disorder Agoraphobia Panic Disorder wAgoraphobia 300.22 Agoraphobia F40.00 Agoraphobia 300.02 Generalized Anxiety F41.1 Generalized Anxiety Disorder Disorder __.__ Substance/Medication- __.__ Substance/Medication-Induced Anxiety Induced Anxiety Disorder Disorder 293.84 Anxiety Disorder Due to F06.4 Anxiety Disorder Due to Another Medical Another Medical Condition Condition 300.00 Other Specified Anxiety F41.8 Other Specified Anxiety Disorder Disorder F41.9 Unspecified Anxiety Disorder 4 CROSSWALK DSM-IV – DSM V – ICD-10 6.29.1 DSM IV DSM IV DSM-IV Description DSM 5 Classification DSM- 5 CODE/ ICD 10 DSM-5 Description Classification CODE CODE Formerly Anxiety 300.3 Obsessive-Compulsive Obsessive- F42 Obsessive-Compulsive Disorder disorders Disorder Compulsive and 300.7 Body Dysmorphic Related Disorders F45.22 Body Dysmorphic Disorder Formerly Disorder Somatoform 300.3 F42 Hoarding Disorder disorders 312.39 Trichotillomania F63.3 Trichotillomania Formerly Impulse- 312.39 Excoriation (Skin-Picking) L98.1 Excoriation (Skin-Picking) Control Disorders Not Elsewhere __.__ Substance/Medication-Induced Obsessive- Classified Compulsive and Related Disorder 294.8 Obsessive-Compulsive F06.8 Obsessive-Compulsive and Related Disorder and Related Disorder Due to Another Medical Condition Due to Another Medical Condition 300.3 Other Specified F42 Other Specified Obsessive-Compulsive and Obsessive-Compulsive Related Disorder and Related Disorder 300.3 Unspecified Obsessive- F42/F43 Unspecified Obsessive-Compulsive and Compulsive and Related Disorder Related Disorder 5 CROSSWALK DSM-IV – DSM V – ICD-10 6.29.1 DSM IV DSM IV DSM-IV Description DSM 5 Classification DSM- 5 CODE/ ICD 10 DSM-5 Description Classification CODE CODE Formerly Other 313.89 Reactive Attachment Trauma- and F94.1 Reactive Attachment Disorder Disorders of Disorder Stressor-Related F94.2 Disinhibited Social Engagement Disorder Infancy Disorders Childhood, or 309.81 Posttraumatic Stress F43.10 Posttraumatic Stress Disorder Adolescence Disorder 308.3 Acute Stress Disorder F43.0 Acute Stress Disorder Formerly Anxiety 309.xx Adjustment Disorders __.__ Adjustment Disorders Disorder Formerly .0 With depressed mood F43.21 With depressed mood Adjustment Disorders .24 With anxiety F43.22 With anxiety .28 With mixed anxiety and F43.23 With mixed anxiety and depressed depressed mood mood .3 With disturbance of F43.24 With disturbance of conduct conduct .4 With mixed disturbance F43.25 With mixed disturbance of emotions of and conduct emotions and conduct .9 Unspecified F43.8 Unspecified 300.00 Anxiety Disorder NOS F43.8 Other Specified Trauma- and Stressor- F43.9 Related Disorder Unspecified Trauma- and Stressor-Related Disorder DSM IV DSM IV DSM-IV Description DSM 5 Classification DSM- 5 CODE/ ICD 10 DSM-5 Description Classification CODE CODE Dissociative 291 Dissociative Disorders Disorders 300.14 Dissociative Identity F44.81 Dissociative Identity Disorder Disorder 300.12 Dissociative Amnesia F44.0 Dissociative Amnesia 300.13 Dissociative fugue F44.1 Specified w/dissociative fugue 300.6 Depersonalization F48.1 Depersonalization/Derealization Disorder Disorder 300.15 Dissociative Disorder NOS F44.89/F44.90 Other Specified Dissociative Disorder 6 CROSSWALK DSM-IV – DSM V – ICD-10 6.29.1 DSM IV Classification DSM IV DSM-IV Description DSM 5 Classification DSM- 5 CODE/ ICD DSM-5 Description CODE 10 CODE Somatoform 300.81 Somatization Disorder Somatic Symptom F45.1 Somatic Symptom Disorder Disorders Undifferentiated Somatoform and Related Disorders 300.82 Disorder F45.21 Illness Anxiety Disorder 300.11 Conversion Disorder __.__ Conversion Disorder F44.4 With weakness of paralysis With abnormal movement F44.4 F44.4 With swallowing symptoms F44.4 With speech symptoms F44.5 With attacks or seizures F44.6 With anesthesia or sensory loss F44.6 With special sensory symptom F44.7 With mixed symptoms 307.xx Pain Disorder Removed from DSM 5 300.7 Hypochondriasis Removed from DSM 5 F54 Psychological Factors Affecting Formerly Factitous Other Medical Conditions Disorder F68.10 Factitious Disorder 300.82 Somatoform Disorder NOS F45.8 Other Specified Somatic Symptom F45.9 and Related Disorder Unspecified Somatic Symptom and Related Disorder 7 CROSSWALK DSM-IV – DSM V – ICD-10 6.29.1 DSM IV Classification DSM IV DSM-IV Description DSM 5 Classification DSM- 5 CODE/ ICD DSM-5 Description CODE 10 CODE Feeding and Eating 307.52 Pica Feeding and Eating F98.3 Pica in children Disorders of Early Disorders Childhood F50.8 Pica in adults 307.53 Rumination Disorder F98.21 Rumination Disorder Formerly->Eating Disorders 307.59 Feeding Disorder of Infancy of Early Removed From DSM 5 Childhood F50.8 Avoidant/Restrictive Food Intake Disorder 307.51 Anorexia Nervosa --. -- Anorexia Nervosa F50.01 Anorexia Nervosa - Restricting type F50.02 Anorexia Nervosa - Bing- eating/purging type 307.50 Bulimia Nervosa F50.2 Bulimia Nervosa F50.8 Binge-Eating Disorder 307.50 Eating Disorder NOS F50.8 Other Specified Feeding or Eating Disorder
Recommended publications
  • First Episode Psychosis an Information Guide Revised Edition

    First Episode Psychosis an Information Guide Revised Edition

    First episode psychosis An information guide revised edition Sarah Bromley, OT Reg (Ont) Monica Choi, MD, FRCPC Sabiha Faruqui, MSc (OT) i First episode psychosis An information guide Sarah Bromley, OT Reg (Ont) Monica Choi, MD, FRCPC Sabiha Faruqui, MSc (OT) A Pan American Health Organization / World Health Organization Collaborating Centre ii Library and Archives Canada Cataloguing in Publication Bromley, Sarah, 1969-, author First episode psychosis : an information guide : a guide for people with psychosis and their families / Sarah Bromley, OT Reg (Ont), Monica Choi, MD, Sabiha Faruqui, MSc (OT). -- Revised edition. Revised edition of: First episode psychosis / Donna Czuchta, Kathryn Ryan. 1999. Includes bibliographical references. Issued in print and electronic formats. ISBN 978-1-77052-595-5 (PRINT).--ISBN 978-1-77052-596-2 (PDF).-- ISBN 978-1-77052-597-9 (HTML).--ISBN 978-1-77052-598-6 (ePUB).-- ISBN 978-1-77114-224-3 (Kindle) 1. Psychoses--Popular works. I. Choi, Monica Arrina, 1978-, author II. Faruqui, Sabiha, 1983-, author III. Centre for Addiction and Mental Health, issuing body IV. Title. RC512.B76 2015 616.89 C2015-901241-4 C2015-901242-2 Printed in Canada Copyright © 1999, 2007, 2015 Centre for Addiction and Mental Health No part of this work may be reproduced or transmitted in any form or by any means electronic or mechanical, including photocopying and recording, or by any information storage and retrieval system without written permission from the publisher—except for a brief quotation (not to exceed 200 words) in a review or professional work. This publication may be available in other formats. For information about alterna- tive formats or other CAMH publications, or to place an order, please contact Sales and Distribution: Toll-free: 1 800 661-1111 Toronto: 416 595-6059 E-mail: [email protected] Online store: http://store.camh.ca Website: www.camh.ca Disponible en français sous le titre : Le premier épisode psychotique : Guide pour les personnes atteintes de psychose et leur famille This guide was produced by CAMH Publications.
  • ICD-10 Mental Health Billable Diagnosis Codes in Alphabetical

    ICD-10 Mental Health Billable Diagnosis Codes in Alphabetical

    ICD-10 Mental Health Billable Diagnosis Codes in Alphabetical Order by Description IICD-10 Mental Health Billable Diagnosis Codes in Alphabetic Order by Description Note: SSIS stores ICD-10 code descriptions up to 100 characters. Actual code description can be longer than 100 characters. ICD-10 Diagnosis Code ICD-10 Diagnosis Description F40.241 Acrophobia F41.0 Panic Disorder (episodic paroxysmal anxiety) F43.0 Acute stress reaction F43.22 Adjustment disorder with anxiety F43.21 Adjustment disorder with depressed mood F43.24 Adjustment disorder with disturbance of conduct F43.23 Adjustment disorder with mixed anxiety and depressed mood F43.25 Adjustment disorder with mixed disturbance of emotions and conduct F43.29 Adjustment disorder with other symptoms F43.20 Adjustment disorder, unspecified F50.82 Avoidant/restrictive food intake disorder F51.02 Adjustment insomnia F98.5 Adult onset fluency disorder F40.01 Agoraphobia with panic disorder F40.02 Agoraphobia without panic disorder F40.00 Agoraphobia, unspecified F10.180 Alcohol abuse with alcohol-induced anxiety disorder F10.14 Alcohol abuse with alcohol-induced mood disorder F10.150 Alcohol abuse with alcohol-induced psychotic disorder with delusions F10.151 Alcohol abuse with alcohol-induced psychotic disorder with hallucinations F10.159 Alcohol abuse with alcohol-induced psychotic disorder, unspecified F10.181 Alcohol abuse with alcohol-induced sexual dysfunction F10.182 Alcohol abuse with alcohol-induced sleep disorder F10.121 Alcohol abuse with intoxication delirium F10.188 Alcohol
  • DSM III and ICD 9 Codes 11-2004

    DSM III and ICD 9 Codes 11-2004

    Diagnoses and ICD-9 Codes: Alphabetical 918.1 Abrasion -Corneal 682 Abscess 372 Abscess Conjunctiva 566 Abscess Corneal 566 Abscess Rectal 682.9 Abscess, Unspecified Site (Cellulitis) 995.81 Abuse, Adult 436 Accident Cerebrovascular, Acute (Less than 8 weeks after Occurrence) 438 Accident, Cerebrovascular, Chronic (Healed or Old) 276.2 Acidosis (Keto-Acidosis) 706.1 Acne 255.4 Addisonian Crisis (Adrenal Cortical Deficiency Hypoadrenalism) 289.3 Adenitis 525.1 Adentia (Loss of Teeth d\Due to Accident, Extraction or Periodontal Diease) 309.89 Adjustment Reaction to Late Life 309.9 Adjustment Reaction-Unspcified 742.2 Agenesis-Cerebral 307.9 Agitation 307.9 Agitation 368.16 Agnosia-Visual 291.9 Alcholick Psychosis 303.9 Alcholism (Addiction, Chronic Dependence) 291.8 Alcohol Withdrawal 291.8 Alcohol Withdrawal 291.2 Alcoholic Dementia 303 Alcoholism 303 Alcoholism 276.3 Alkalosis 995.3 Allergies, Cause Unspecifed (Reaction) 335.2 ALS (A;myothophic Lateral Sclerosis) 331 Alzheimers 331 Alzheimers Disease 362.34 Amaurosis Fugax 305.7 Amphetamine Abuse (Meth Abuse) 897 Amputation (Legs) 736.89 Amputation, Leg, Status Post (Above Knee, Below Knee) 736.9 Amputee, Site Unspecified (Acquired Deformity) 285.9 Anemia 284.9 Anemia Aplastic (Hypoplastic Bone Morrow) 280 Anemia Due to loss of Blood 281 Anemia Pernicious 280.9 Anemia, Iron Deficiency, Unspecified 285.9 Anemia, Unspecified (Normocytic, Not due to blood loss) 281.9 Anemia, Unspecified Deficiency (Macrocytic, Nutritional 441.5 Aneurysm Aortic, Ruptured 441.1 Aneurysm, Abdominal 441.3 Aneurysm,
  • Eating Disorders: About More Than Food

    Eating Disorders: About More Than Food

    Eating Disorders: About More Than Food Has your urge to eat less or more food spiraled out of control? Are you overly concerned about your outward appearance? If so, you may have an eating disorder. National Institute of Mental Health What are eating disorders? Eating disorders are serious medical illnesses marked by severe disturbances to a person’s eating behaviors. Obsessions with food, body weight, and shape may be signs of an eating disorder. These disorders can affect a person’s physical and mental health; in some cases, they can be life-threatening. But eating disorders can be treated. Learning more about them can help you spot the warning signs and seek treatment early. Remember: Eating disorders are not a lifestyle choice. They are biologically-influenced medical illnesses. Who is at risk for eating disorders? Eating disorders can affect people of all ages, racial/ethnic backgrounds, body weights, and genders. Although eating disorders often appear during the teen years or young adulthood, they may also develop during childhood or later in life (40 years and older). Remember: People with eating disorders may appear healthy, yet be extremely ill. The exact cause of eating disorders is not fully understood, but research suggests a combination of genetic, biological, behavioral, psychological, and social factors can raise a person’s risk. What are the common types of eating disorders? Common eating disorders include anorexia nervosa, bulimia nervosa, and binge-eating disorder. If you or someone you know experiences the symptoms listed below, it could be a sign of an eating disorder—call a health provider right away for help.
  • Deep Brain Stimulation in Psychiatric Practice

    Deep Brain Stimulation in Psychiatric Practice

    Clinical Memorandum Deep brain stimulation in psychiatric practice March 2018 Authorising Committee/Department: Board Responsible Committee/Department: Section of Electroconvulsive Therapy and Neurostimulation Document Code: CLM PPP Deep brain stimulation in psychiatric practice The Royal Australian and New Zealand College of Psychiatrists (RANZCP) has developed this clinical memorandum to inform psychiatrists who are involved in using DBS as a treatment for psychiatric disorders. Clinical trials into the use of Deep Brain Stimulation (DBS) to treat psychiatric disorders such as depression, obsessive-compulsive disorder, substance use disorders, and anorexia are occurring worldwide, including within Australia. Although overall the existing literature shows promise for DBS in the treatment of psychiatric disorders, its use is still an emerging treatment and requires a stronger clinical evidence base of randomised control trials to develop a substantial body of evidence to identify and support its efficacy (Widge et al., 2016; Barrett, 2017). The RANZCP supports further research and clinical trials into the use of DBS for psychiatric disorders and acknowledges that it has potential application as a treatment for appropriately selected patients. Background DBS is an established treatment for movement disorders such as Parkinson’s disease, tremor and dystonia, and has also been used in the control of movement disorder associated with severe and medically intractable Tourette syndrome (Cannon et al., 2012). In Australia the Therapeutic Goods Administration has approved devices for DBS. It is eligible for reimbursement under the Medicare Benefits Schedule for the treatment of Parkinson’s disease but not for other neurological or psychiatric disorders. As the use of DBS in the treatment of psychiatric disorders is emerging, it is currently only available in speciality clinics or hospitals under research settings.
  • Brief Psychotic Disorder Diagnostic Criteria 298.8 (F23)

    Brief Psychotic Disorder Diagnostic Criteria 298.8 (F23)

    Brief Psychotic Disorder Diagnostic Criteria 298.8 (F23) A. Presence of one (or more) of the following symptoms. At least one of these must be (1), (2), or (3): 1. Delusions. 2. Hallucinations. 3. Disorganized speech (e.g., frequent derailment or incoherence). 4. Grossly disorganized or catatonic behavior. Note: Do not include a symptom if it is a culturally sanctioned response. B. Duration of an episode of the disturbance is at least 1 day but less than 1 month, with eventual full return to premorbid level of functioning. C. The disturbance is not better explained by major depressive or bipolar disorder with psychotic features or another psychotic disorder such as schizophrenia or catatonia, and is not attributable to the physiological effects of a substance (e.g., a drug of abuse, a medication) or another medical condition. Specify if: With marked stressor(s) (brief reactive psychosis): If symptoms occur in response to events that, singly or together, would be markedly stressful to almost anyone in similar circumstances in the individual’s culture. Without marited stressor(s): If symptoms do not occur in response to events that, singly or together, would be markedly stressful to almost anyone in similar circumstances in the individual’s culture. With postpartum onset: If onset is during pregnancy or within 4 weeks postpartum. Specify if: With catatonia (refer to the criteria for catatonia associated with another mental disorder, pp. 119-120, for definition) Coding note: Use additional code 293.89 (F06.1) catatonia associated with brief psychotic disorder to indicate the presence of the comorbid catatonia. Specify current severity: Severity is rated by a quantitative assessment of the primary symptoms of psychosis, including delusions, hallucinations, disorganized speech, abnormal psychomotor behavior, and negative symptoms.
  • The Clinical Presentation of Psychotic Disorders Bob Boland MD Slide 1

    The Clinical Presentation of Psychotic Disorders Bob Boland MD Slide 1

    The Clinical Presentation of Psychotic Disorders Bob Boland MD Slide 1 Psychotic Disorders Slide 2 As with all the disorders, it is preferable to pick Archetype one “archetypal” disorder for the category of • Schizophrenia disorder, understand it well, and then know the others as they compare. For the psychotic disorders, the diagnosis we will concentrate on will be Schizophrenia. Slide 3 A good way to organize discussions of Phenomenology phenomenology is by using the same structure • The mental status exam as the mental status examination. – Appearance –Mood – Thought – Cognition – Judgment and Insight Clinical Presentation of Psychotic Disorders. Slide 4 Motor disturbances include disorders of Appearance mobility, activity and volition. Catatonic – Motor disturbances • Catatonia stupor is a state in which patients are •Stereotypy • Mannerisms immobile, mute, yet conscious. They exhibit – Behavioral problems •Hygiene waxy flexibility, or assumption of bizarre • Social functioning – “Soft signs” postures as most dramatic example. Catatonic excitement is uncontrolled and aimless motor activity. It is important to differentiate from substance-induced movement disorders, such as extrapyramidal symptoms and tardive dyskinesia. Slide 5 Disorders of behavior may involve Appearance deterioration of social functioning-- social • Behavioral Problems • Social functioning withdrawal, self neglect, neglect of • Other – Ex. Neuro soft signs environment (deterioration of housing, etc.), or socially inappropriate behaviors (talking to themselves in
  • 1 SUPPLEMENTARY MATERIAL Burden of Illness Among

    1 SUPPLEMENTARY MATERIAL Burden of Illness Among

    SUPPLEMENTARY MATERIAL Burden of illness among patients with dementia-related psychosis Monica Frazer, PhD; Victor Abler, DO; Rachel Halpern, PhD; Ben Skoog, PharmD; and Nazia Rashid, PharmD Supplementary Table 1. Diagnosis and Medication Code List 1 Supplementary Table 1. Diagnosis and Medication Code List Code Code Type Description Psychosis Inclusion 290.12 ICD-9 Dx Presenile dementia with delusional features 290.20 ICD-9 Dx Senile dementia with delusional features 290.42 ICD-9 Dx Vascular dementia with delusions 290.8 ICD-9 Dx Other specified senile psychotic conditions 290.9 ICD-9 Dx Unspecified senile psychotic condition 293.81 ICD-9 Dx Psychotic disorder with delusions in conditions classified elsewhere Psychotic disorder with hallucinations in conditions classified 293.82 ICD-9 Dx elsewhere 297.1 ICD-9 Dx Delusional disorder 298.0 ICD-9 Dx Depressive type psychosis 298.1 ICD-9 Dx Excitative type psychosis 298.4 ICD-9 Dx Psychogenic paranoid psychosis 298.8 ICD-9 Dx Other and unspecified reactive psychosis 298.9 ICD-9 Dx Unspecified psychosis 368.16 ICD-9 Dx Psychophysical visual disturbances 780.1 ICD-9 Dx Hallucinations Psychotic disorder with hallucinations due to known physiological F060 ICD-10 Dx condition Psychotic disorder with delusions due to known physiological F062 ICD-10 Dx condition F22 ICD-10 Dx Delusional disorders F23 ICD-10 Dx Brief psychotic disorder Other psychotic disorder not due to a substance or known F28 ICD-10 Dx physiological condition Unspecified psychosis not due to a substance or known physiological
  • Dsm-5 Diagnostic Criteria for Eating Disorders Anorexia Nervosa

    Dsm-5 Diagnostic Criteria for Eating Disorders Anorexia Nervosa

    DSM-5 DIAGNOSTIC CRITERIA FOR EATING DISORDERS ANOREXIA NERVOSA DIAGNOSTIC CRITERIA To be diagnosed with anorexia nervosa according to the DSM-5, the following criteria must be met: 1. Restriction of energy intaKe relative to requirements leading to a significantly low body weight in the context of age, sex, developmental trajectory, and physical health. 2. Intense fear of gaining weight or becoming fat, even though underweight. 3. Disturbance in the way in which one's body weight or shape is experienced, undue influence of body weight or shape on self-evaluation, or denial of the seriousness of the current low body weight. Even if all the DSM-5 criteria for anorexia are not met, a serious eating disorder can still be present. Atypical anorexia includes those individuals who meet the criteria for anorexia but who are not underweight despite significant weight loss. Research studies have not found a difference in the medical and psychological impacts of anorexia and atypical anorexia. BULIMIA NERVOSA DIAGNOSTIC CRITERIA According to the DSM-5, the official diagnostic criteria for bulimia nervosa are: • Recurrent episodes of binge eating. An episode of binge eating is characterized by both of the following: o Eating, in a discrete period of time (e.g. within any 2-hour period), an amount of food that is definitely larger than most people would eat during a similar period of time and under similar circumstances. o A sense of lacK of control over eating during the episode (e.g. a feeling that one cannot stop eating or control what or how much one is eating).
  • Accurate Diagnosis of Primary Psychotic Disorders the Care Transitions Network

    Accurate Diagnosis of Primary Psychotic Disorders the Care Transitions Network

    Accurate Diagnosis of Primary Psychotic Disorders The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental Health Netsmart Technologies Objectives • By the completion of this webinar, participants should understand that the diagnoses of primary psychotic disorders will change early in the course of illness. • Participants will understand that when mood and psychotic symptoms overlap, diagnosis can further change over the patient’s lifetime. • Participants will be be able to use DSM-5 criteria to diagnose primary psychotic disorders and schizoaffective disorder. What diagnoses are on your differential? Think broadly. Differential should Include… • Schizophrenia • Schizophreniform Disorder • Brief Psychotic Disorder • Delusional Disorder • Other Specified Psychotic Disorder • Unspecified Psychotic Disorder Differential should exclude… Symptoms due to a medical condition or the effects of a medication or substance abuse Mood disorders with psychosis The timeline of psychotic symptoms is crucial for distinguishing between schizophrenia-spectrum disorders For psychotic disorders, the most accurate diagnosis can change as symptoms change over time Delusional Disorder Unspecified Psychotic Schizophreniform Schizophrenia Disorder Disorder Brief Psychotic Disorder JANUARY FEBRUARY MARCH APRIL MAY JUNE Symptoms resolve Brief Psychotic Disorder Symptoms Delusional Disorder resolve Schizophreniform Disorder Schizophrenia 6 month mark 1 month mark Also important for distinguishing schizophrenia-spectrum disorders are …..the psychotic symptom domains ….the frequency & severity of symptoms Schizophrenia Schizophrenia Negative Signs & Disorganized Signs 5 Symptoms Grossly Disorganized or Catatonic Behavior 4 Disorganized Speech 3 ≥ 2/5 key symptom domains Each present for a significant portion of time during a 1 month Positive Symptoms period. (Or less if successfully treated).
  • Patients' and Carers' Perspectives of Psychopharmacological

    Patients' and Carers' Perspectives of Psychopharmacological

    Chapter Patients’ and Carers’ Perspectives of Psychopharmacological Interventions Targeting Anorexia Nervosa Symptoms Amabel Dessain, Jessica Bentley, Janet Treasure, Ulrike Schmidt and Hubertus Himmerich Abstract In clinical practice, patients with anorexia nervosa (AN), their carers and clini- cians often disagree about psychopharmacological treatment. We developed two corresponding questionnaires to survey the perspectives of patients with AN and their carers on psychopharmacological treatment. These questionnaires were dis- tributed to 36 patients and 37 carers as a quality improvement project on a specialist unit for eating disorders at the South London and Maudsley NHS Foundation Trust. Although most patients did not believe that medication could help with AN, the majority thought that medication for AN should help with anxiety (61.1%), con- centration (52.8%), sleep problems (52.8%) and anorexic thoughts (55.6%). Most of the carers shared the view that drug treatment for AN should help with anxiety (54%) and anorexic thoughts (64.8%). Most patients had concerns about potential weight gain, increased appetite, changes in body shape and metabolism during psychopharmacological treatment. By contrast, the majority of carers were not concerned about these specific side effects. Some of the concerns expressed by the patients seem to be AN-related. However, their desire for help with anxiety and anorexic thoughts, which is shared by their carers, should be taken seriously by clinicians when choosing a medication or planning psychopharmacological studies. Keywords: anorexia nervosa, psychopharmacological treatment, treatment effects, side effects, opinion survey, patients, carers 1. Introduction 1.1 Anorexia nervosa Anorexia nervosa (AN) is an eating disorder. According to the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) [1], its diagnostic criteria are significantly low body weight, intense fear of weight gain, and disturbed body perception.
  • Appropriate Use of Antipsychotics in Dementia Is Also an Issue in the Community, in Supportive Living Facilities and in Acute Care

    Appropriate Use of Antipsychotics in Dementia Is Also an Issue in the Community, in Supportive Living Facilities and in Acute Care

    1 Antipsychotics are a class of medications developed in the 1950’s to treat the symptoms of schizophrenia, enabling people with this illness to live in the community Typical antipsychotics such as Haldol and Largactil came to be used for some of the symptoms and behaviours of dementia. Concern developed regarding side-effects such as tardive dyskinesia (a movement disorder that can be permanent). When atypical antipsychotics were introduced in the 1990’s, it was believed they had fewer side-effects. Over time, we learned they don’t have fewer side-effects - just different side-effect profiles. As the use of antipsychotics grows, so do reports of harm. Aripiprazole is the newest atypical antipsychotic and is considerably more expensive than the generic second-generation atypical antipsychotics. Utilization and popularity of this newest antipsychotic is growing, unfortunately without outcome related evidence. It’s expected that reports of harm will also accumulate with aripiprazole. There is a recent tendency to revert back to Haldol and other typical antipsychotics, which are NOT safer, in light of a growing number of Health Canada alerts regarding atypical antipsychotics. 2 It’s important to emphasize this is not an initiative to eliminate antipsychotics but to use antipsychotics appropriately. People with chronic mental health conditions such as schizophrenia or Huntington’s Chorea likely require long term use, though the dosage may need to be reassessed as they age. Antipsychotics may be used as adjunctive treatment in refractory depression, and for other chronic mental health conditions. Antipsychotics may also be helpful in distressing psychosis - Dementia itself may cause a distressing psychosis –in this case, antipsychotics are a temporary treatment, as needs change over time with disease progression.